FDA approves Tygacil for CAP

Wyeth (NYSE:WYE) said FDA approved an sNDA for Tygacil tigecycline to treat community-acquired pneumonia (CAP). The IV glycylcycline antibiotic is marketed to treat complicated skin and skin structure...